Immunocore
IMCR
IMCR
115 hedge funds and large institutions have $1.34B invested in Immunocore in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 44 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 130 → 115 (-15)
16% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 44
52% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 27
Holders
115
Holding in Top 10
2
Calls
$1.76M
Puts
$1.22M
Top Buyers
| 1 | +$38.7M | |
| 2 | +$19.5M | |
| 3 | +$16.4M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$14.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.8M |
Top Sellers
| 1 | -$19M | |
| 2 | -$13.7M | |
| 3 | -$12.3M | |
| 4 |
Morgan Stanley
New York
|
-$8.67M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$8.41M |